P
Pascal Piedbois
Publications - 1
Citations - 117
Pascal Piedbois is an academic researcher. The author has contributed to research in topics: Survival rate & Tolerability. The author has an hindex of 1, co-authored 1 publications receiving 112 citations.
Papers
More filters
Journal ArticleDOI
A randomized multi-center phase II trial of the angiogenesis inhibitor Cilengitide (EMD 121974) and gemcitabine compared with gemcitabine alone in advanced unresectable pancreatic cancer
Helmut Friess,Jan M. Langrehr,Helmut Oettle,Jochen Raedle,Marco Niedergethmann,Christian Dittrich,Dieter K Hossfeld,Herbert Stöger,Bart Neyns,Peter Herzog,Pascal Piedbois,Frank Dobrowolski,Werner Scheithauer,Robert E. Hawkins,Frieder Katz,Peter Balcke,Jan B. Vermorken,Simon van Belle,Neville Davidson,Albert Abad Esteve,Daniel Castellano,Jörg Kleeff,Adrien A. Tempia-Caliera,Andreas Kovar,Johannes Nippgen +24 more
TL;DR: The combination regimen was well tolerated with no adverse effects on the safety, tolerability and pharmacokinetics of either agent and the observations lay in the range of other clinical studies in this setting.